GRS proposes a pharmacoeconomic evaluation of your products; a research which assist in making healthcare decisions,more successful access to markets and better commercialisation of products
  • Cost-minimization analysis (method of calculating drug costs to project the least costly drug or therapeutic modality)
  • Cost-benefit analysis (compares the financial costs with the benefits of two or more health care treatments or programs)
  • cost-effectiveness analysis (method of comparing the cost and effectiveness of two or more alternatives)
  • Cost-utility analysis(compares two or more alternative courses of action in terms of costs and outcomes)